Insider Transactions Reported by 30 Insiders of Tyra Biosciences, Inc.

Symbol
TYRA on Nasdaq
Location
Carlsbad, CA

Insiders trading volume in the past year

Tyra Biosciences, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Boxer Capital Management, LLC Other* $125,264,455 18 Oct 2024
Nina S. Kjellson Director $122,459,032 05 Feb 2025
RA CAPITAL MANAGEMENT, L.P. Director, 10%+ Owner $116,935,617 +$15,320,006 +15% 12 Jun 2025
Robert J. More Director $95,585,625 -$5,250,026 -5.2% 19 Dec 2025
Boxer Capital, LLC Other* $94,186,205 06 Feb 2024
Todd Harris President and CEO, Director $46,030,418 13 Mar 2026
Alta Partners NextGen Fund II Management, LLC 10%+ Owner $26,844,267 17 Sep 2021
Cormorant Asset Management, LP Former 10% Owner $7,039,083 17 Sep 2021
Daniel Bensen Chief Discovery Officer $4,904,256 -$4,811,300 -50% 12 Feb 2026
Canaan XI L.P. 10%+ Owner $3,114,472 17 Sep 2021
Robert L. Hudkins Chief Technology Officer $1,799,857 15 Sep 2022
Ronald Swanson V Chief Scientific Officer $1,797,738 06 Sep 2022
Esther van den Boom Chief Financial Officer $1,582,525 15 Sep 2022
Adele M. Gulfo Director $670,011 29 Jan 2025
Hiroomi Tada Chief Medical Officer $568,656 15 Mar 2024
Alan Fuhrman Chief Financial Officer $547,636 13 Mar 2026
Piyush R. Patel Chief Development Officer $485,491 21 Feb 2023
Gilla Kaplan Director $276,161 -$628,263 -69% 17 Jun 2025
MVA Investors, LLC 10%+ Owner $148,205 09 Feb 2023
John Stephen Healy General Counsel and Secretary 01 Mar 2022
Isan Chen Director 31 May 2023
Jake Simson Director 29 May 2025
Bhavesh Ashar Chief Operating Officer 01 Dec 2025
Douglas J. Warner Chief Medical Officer 07 Aug 2025
Rehan Verjee Director 29 May 2025
Siddarth Subramony Director, 10%+ Owner 29 May 2024
Ali D. Fawaz General Counsel and Secretary 16 May 2022
Susan Moran Director 29 May 2025
Stephen Michael Rothenberg Director 29 May 2025
Melissa McCracken Director 14 Sep 2021

Recent Insider Transactions by Companies or Individuals for Tyra Biosciences, Inc.

Showing up to 300 most recent insider transactions from the last 12 months.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
Alan Fuhrman TYRA Common Stock Award 9.3% 1,376 16,164 13 Mar 2026 Direct
Todd Harris TYRA Common Stock Award 0.11% 1,463 1,358,631 13 Mar 2026 Direct
Daniel Bensen TYRA Common Stock Sale -5.16% $262,965 $32.87 -8,000 146,981 12 Feb 2026 Direct
Daniel Bensen TYRA Common Stock Sale -4.91% $228,186 $28.52 -8,000 154,981 12 Jan 2026 Direct
Robert J. More TYRA Common Stock Sale -0.26% $250,000 $25.00 -10,000 3,823,425 19 Dec 2025 See footnote
Daniel Bensen TYRA Common Stock Sale -4.68% $181,159 $22.64 -8,000 162,981 12 Dec 2025 Direct
Bhavesh Ashar TYRA Stock Option (Right to Buy) Award 300,000 300,000 01 Dec 2025 Direct
Robert J. More TYRA Common Stock Sale -6.05% $5,000,026 $20.25 -246,871 3,833,425 21 Nov 2025 See footnote
Daniel Bensen TYRA Common Stock Sale -22.6% $815,297 $16.32 -49,956 170,981 19 Nov 2025 Direct
Daniel Bensen TYRA Common Stock Sale -25.5% $1,215,627 $16.07 -75,633 220,937 18 Nov 2025 Direct
Daniel Bensen TYRA Common Stock Sale -6.34% $324,798 $16.18 -20,072 296,570 17 Nov 2025 Direct
Daniel Bensen TYRA Common Stock Sale -25.8% $1,765,489 $16.02 -110,228 316,642 14 Nov 2025 Direct
Daniel Bensen TYRA Common Stock Sale -0.26% $17,780 $16.00 -1,111 426,870 13 Nov 2025 Direct
Alan Fuhrman TYRA Common Stock Award 4.98% 701 14,788 15 Sep 2025 Direct
Alan Fuhrman TYRA Stock Option (Right to Buy) Award 170,000 170,000 07 Aug 2025 Direct
Daniel Bensen TYRA Stock Option (Right to Buy) Award 170,000 170,000 07 Aug 2025 Direct
Douglas J. Warner TYRA Stock Option (Right to Buy) Award 200,000 200,000 07 Aug 2025 Direct
Todd Harris TYRA Stock Option (Right to Buy) Award 570,000 570,000 07 Aug 2025 Direct
Gilla Kaplan TYRA Common Stock Sale -25.3% $93,596 $9.78 -9,568 28,231 18 Jun 2025 Direct
Gilla Kaplan TYRA Common Stock Sale -0.03% $104 $10.35 -10 37,799 17 Jun 2025 Direct
Ra Capital Management, L.P. TYRA Common Stock Purchase 0.12% $119,666 $10.13 11,813 10,259,291 16 Jun 2025 See footnotes
Gilla Kaplan TYRA Common Stock Sale -15.3% $70,726 $10.38 -6,814 37,809 16 Jun 2025 Direct
Ra Capital Management, L.P. TYRA Common Stock Purchase 1.19% $1,225,703 $10.20 120,167 10,247,478 13 Jun 2025 See footnotes
Gilla Kaplan TYRA Common Stock Sale -25.2% $154,582 $10.31 -15,000 44,623 13 Jun 2025 Direct
Ra Capital Management, L.P. TYRA Common Stock Purchase 0.31% $319,331 $10.20 31,307 10,127,311 12 Jun 2025 See footnotes
Gilla Kaplan TYRA Common Stock Sale -33.5% $309,255 $10.31 -30,000 59,623 12 Jun 2025 Direct
Ra Capital Management, L.P. TYRA Common Stock Purchase 1.89% $1,904,002 $10.19 186,850 10,096,004 09 Jun 2025 See footnotes
Ra Capital Management, L.P. TYRA Common Stock Purchase 2.2% $2,141,873 $10.04 213,334 9,909,154 05 Jun 2025 See footnotes
Ra Capital Management, L.P. TYRA Common Stock Purchase 11.5% $9,609,430 $9.63 997,864 9,695,820 04 Jun 2025 See footnotes
Ra Capital Management, L.P. TYRA Stock Option (Right to Buy) Award 22,200 22,200 29 May 2025 See footnotes
Rehan Verjee TYRA Stock Option (Right to Buy) Award 22,200 22,200 29 May 2025 Direct
Jake Simson TYRA Stock Option (Right to Buy) Award 22,200 22,200 29 May 2025 Direct
Robert J. More TYRA Stock Option (Right to Buy) Award 22,200 22,200 29 May 2025 Direct
Susan Moran TYRA Stock Option (Right to Buy) Award 22,200 22,200 29 May 2025 Direct
Stephen Michael Rothenberg TYRA Stock Option (Right to Buy) Award 22,200 22,200 29 May 2025 Direct
Gilla Kaplan TYRA Stock Option (Right to Buy) Award 22,200 22,200 29 May 2025 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.